Abstract
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
Lennart T H Jacobsson, Carl Turesson, Anders Gülfe, Meliha C Kapetanovic, Ingemar F Petersson, Tore Saxne and Pierre Geborek
The Journal of Rheumatology July 2005, 32 (7) 1213-1218;
Lennart T H Jacobsson
Carl Turesson
Anders Gülfe
Meliha C Kapetanovic
Ingemar F Petersson
Tore Saxne
In this issue
The Journal of Rheumatology
Vol. 32, Issue 7
1 Jul 2005
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
Lennart T H Jacobsson, Carl Turesson, Anders Gülfe, Meliha C Kapetanovic, Ingemar F Petersson, Tore Saxne, Pierre Geborek
The Journal of Rheumatology Jul 2005, 32 (7) 1213-1218;
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
Lennart T H Jacobsson, Carl Turesson, Anders Gülfe, Meliha C Kapetanovic, Ingemar F Petersson, Tore Saxne, Pierre Geborek
The Journal of Rheumatology Jul 2005, 32 (7) 1213-1218;